• Info
  • Insider Ownership

Insider Trading & Ownership of Kevin C. Oboyle

Location
Carlsbad, CA
Summary
The estimated net worth of Kevin C. Oboyle is at least $1,090,539 dollars as of 24 Jul 2025. Kevin C. Oboyle is the Director of Outset Medical, Inc. and owns shares of Outset Medical, Inc. (OM) stock worth about $369K. Kevin C. Oboyle is the Director of iRhythm Technologies, Inc. and owns shares of iRhythm Holdings, Inc. (IRTC) stock worth about $313.3K. Kevin C. Oboyle is the Director of CARLSMED, INC. and owns shares of CARLSMED, INC. (CARL) stock worth about $251.3K. Kevin C. Oboyle is the Director of Sientra, Inc. and owns shares of PROJECT SAGE OLDCO, INC. stock worth about $156.9K.
Signature
/s/ Leonard Greenstein, as attorney-in-fact for Kevin O'Boyle
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Kevin C. Oboyle and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sponsored

Quick Takeaways

  • Kevin C. Oboyle has 5 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $1,090,539.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Outset Medical, Inc. ($369,005).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Kevin C. Oboyle

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
OM Outset Medical, Inc. Director $369,005 02 Jun 2025
IRTC iRhythm Technologies, Inc. Director $313,311 07 Jul 2025
CARL CARLSMED, INC. Director $251,329 22 Jul 2025
SIEN Sientra, Inc. Director $156,894 09 Jun 2022
NVRO NEVRO CORP Director $0 03 Apr 2025

Insider Transactions Reported by Kevin C. Oboyle:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.